The course of HBV overinfection during NANB CAH in treatment with IFN.
D000328:Adult; D006509:Hepatitis B / Q000150:complications* / Q000188:drug therapy*; D006526:Hepatitis C / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D007372:Interferons / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000627:therapeutic use
D011994:Recombinant Proteins; D007372:Interferons